SCHEMBL23977899

SCHEMBL23977899

O=c1cnc2cc(Br)c(Cl)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.47
RPS6KA3 P51812 2/20 0.47
MAPKAPK2 P49137 1/20 0.47
PLK3 Q9H4B4 1/20 0.47
ALDH1A1 P00352 2/20 0.43
HCAR1 Q9BXC0 1/20 0.38
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
LMNA P02545 2/20 0.35
GRIA1 P42261 2/20 0.35
GRIA2 P42262 2/20 0.35
GRIA3 P42263 2/20 0.35
GRIA4 P48058 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35
GRIN3A Q8TCU5 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964021 1.00 CSNK2A1 (0.47) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL2947345 0.85 MAPKAPK2 (0.53) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL31214307 0.85 RPS6KA3 (0.53) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL29965007 0.79 RPS6KA3 (0.47) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL23977871 0.79 RPS6KA3 (0.47) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL18426240 0.76 MAPKAPK2 (0.44) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL16536360 0.76 GRIN2D (0.54) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL30806787 0.74 ALDH1A1 (0.56) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL21541889 0.73 MAPKAPK2 (0.47) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1
SCHEMBL18426438 0.72 MAPKAPK2 (0.44) CSNK2A1RPS6KA3MAPKAPK2PLK3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135636-A Quinoxalinone derivatives as irreversible inhibitors of KRAS G12C mutant proteins 北京泰德制药股份有限公司 2022-09-30 CN disclosed
WO-2021219091-A2 QUINOXALINONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN 北京泰德制药股份有限公司 (CN) 2021-11-04 WO disclosed